Ultherapy vs Thermage in Korea — plus Oligio, Volnewmer and 10Therma

The FDA describes the Ulthera system as focused ultrasound with supplementary imaging. Its PRIME instructions distinguish imaging from treatment delivery. Thermage's manufacturer identifies its technology as monopolar RF; the FLX regulatory document describes delivery through a treatment tip with cooling. These describe how the systems work, not which result you will get.

TENTECH identifies 10THERMA as monopolar RF and lists 10THERA separately as HIFU. The final M matters. A menu saying 'Korean Thermage' still needs an actual manufacturer and model. Sharing an energy category does not make two brands or their consumables interchangeable.

Oligio and Volnewmer are the names most often placed next to Thermage on Korean menus. Their US 510(k) summaries are useful for identification. Wontech describes The Oligio as a 6.78 MHz radio frequency therapy system with a handpiece, return pads, treatment tips and cooling, and names Thermage FLX (K170758) as its predicate device. Classys describes Volnewmer as a noninvasive monopolar RF therapy system at 6.78 MHz and also names Thermage FLX as its predicate.

A predicate is the already-cleared device a manufacturer compares against to show substantial equivalence for the cleared indication. In these filings, that indication is dermatologic electrocoagulation and hemostasis of soft tissue. It is not a statement that the cosmetic result, comfort or number of sessions matches Thermage. Names also travel: Classys's own company history writes “Everesse (Volnewmer)”, the same way it pairs Shurink with Ultraformer, so a menu showing Everesse should be confirmed against the Volnewmer system. A 2024 Oligio X filing states it shares The Oligio's specification and differs only in color and user interface; a 2025 filing then lists a slightly lower maximum output and hardware changes, so an 'X' on the menu should still be confirmed as the device actually in the room.

For your comparison, treat each brand as its own purchase: exact model, tip, named areas, stated count and what that count measures. A Thermage FLX quote and an Oligio or Volnewmer quote can be listed side by side, but a lower price per shot does not convert one into the other.

A count needs context. Ultherapy PRIME instructions distinguish lines delivered during treatment from a transducer's remaining capacity. Ask whether a quoted number describes the treatment planned for you, a component's capacity, or a package split across areas. Do not turn one into the other.

Keep the clinic's unit, whether lines, shots, pulses or REPs, and ask what it counts on that device. Do not divide prices by unlike counts to declare a better deal. Model, area, consumable and scope still need to match; energy settings and suitability require the treating clinician's judgment.

A 2019 randomized, evaluator-blinded split-face study enrolled 20 people with mild to moderate laxity. It compared microfocused ultrasound with visualization against monopolar RF through six months. The abstract reports improvement with both and no statistically significant between-treatment difference on its reported outcomes.

That small study does not prove equivalence or a universal winner. The abstract does not identify today's PRIME and FLX generations, so we cannot present it as a current-model head-to-head. We reviewed the abstract, not the full text, and cannot assess every method or funding detail from it.

We do not have a current, verified Seoul price survey for matching models and treatment scopes. A broad price band would hide the differences you need to see. Request dated, itemized quotes in the original currency, then send each clinic the same questions.

The manufacturers describe possible adverse effects: Ultherapy instructions include pain, swelling and transient nerve effects; Thermage safety information includes pain, swelling and burns. This is not a complete list or a comparison of rates. A reassuring menu phrase cannot replace device-specific screening and consent.

Tell the clinician about relevant medical history and implants, your event or photo date, departure, and access to follow-up. Ask which reactions and less common complications matter for the proposed treatment, what to do if they occur, and whether your schedule makes postponement more sensible. This guide gives no fixed recovery or safe-to-fly interval.

If a clinic suggests combining ultrasound and RF, ask why both are proposed, what each adds, what alternatives exist, and how the total and follow-up change. A package name alone is not a reason to schedule both together.

Keep a dated copy of each quote, including a source link or screenshot. In Analyze, enter offers separately, preserve the exact model and unit, and correct missing or misread fields. The tool organizes stated information; it does not authenticate a device or decide suitability.

Use the clinic verification checklist for the clinic's identity and registered name. When a clinic answers, update the saved comparison from Recent plans. A clearer question, a consultation, or a decision to wait can all be useful outcomes.